. Author manuscript; available in PMC: 2018 Apr 11.

Published in final edited form as: J Cardiovasc Transl Res. 2017 Jan 19;10(3):285–294. doi: 10.1007/s12265-017-9729-1

Table 1.

Baseline characteristics according to HFpEF status

	No HFpEF	Baseline HFpEF	Incident HFpEF	Any HFpEF
Characteristics	2754 (90.7)	123 (4.5)	161 (5.8)	284 (9.3)
Age, years	71 (68–75)	76 (71–79)^***	74 (70–77)^***	74 (70–78)^***
Male, N (%)	1084 (39)	56 (46)	77 (48)^*	133 (47)^*
Atrial fibrillation, N (%)	101 (4)	26 (21)^***	21 (13)^***	47 (17)^***
Hypertension, N (%)	1049 (38)	67 (54)^***	86 (53)^***	153 (54)^***
COPD, N (%)	316 (12)	29 (24)^***	25 (16)	54 (20)^***
Coronary artery disease, N (%)	551 (20)	73 (59)^***	66 (41)^***	157 (55)^***
BMI, kg/m²—median (Q1–Q3)	25.7 (23.2–28.5)	24.9 (23.1–29.9)	26.3 (24.1–29.0)^*	26.1 (23.5–29.4)^*
Diabetes mellitus, N (%)	316 (12)	38 (31)^***	36 (22)^***	74 (26)^***
Anemia, N (%)	378 (14)	30 (25)^***	29 (18)	59 (21)^***
≥Stage 4 CKD, N (%)	1104 (40)	79 (64)^***	68 (42)	147 (52)^***

COPD chronic obstructive pulmonary disease, BMI body mass index, CKD chronic kidney disease ≥stage 4

Q1 quartile 1, Q3 quartile 3

p < 0.05,

^**

p < 0.01,

^***

p < 0.001 vs. control (no HFpEF)